DOI: 10.1128/MCB.00949-09
Article Information
PubMed
Published By
History
- Received July 20, 2009
- Returned for modification August 14, 2009
- Accepted May 14, 2010
- Published online July 9, 2010.
Copyright & Usage
Copyright © 2010 American Society for Microbiology
Article Versions
- Accepted Manuscript version (June 01, 2010).
- You are viewing the most recent version of this article.
Author Information
- Mark S. Phong1,5,
- Robert D. Van Horn2,
- Shuyu Li3,
- Gregory Tucker-Kellogg1,6,
- Uttam Surana4,5 and
- Xiang S. Ye2*
- 1Lilly Singapore Center for Drug Discovery, Pte Ltd. (Eli Lilly & Company), Singapore, Republic of Singapore
- 2Cancer Research Division, Lilly Research Labs, Lilly Corporate Center, Eli Lilly & Company, Indianapolis, Indiana 46285
- 3Translational Science, Lilly Research Labs, Lilly Corporate Center, Eli Lilly & Company, Indianapolis, Indiana 46285
- 4Institute of Molecular and Cell Biology, Agency of Science, Technology, and Research, Singapore, Republic of Singapore
- 5Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Republic of Singapore
- 6Department of Biological Sciences, Faculty of Science, National University of Singapore, Singapore, Republic of Singapore
- ↵* Corresponding author. Mailing address: Lilly Research Labs, Lilly Corporate Center, DC 0546, Indianapolis, IN 46285. Phone: (317) 277-1467. Fax: (317) 276-6510. E-mail: ye_xiang_s{at}lilly.com
† Supplemental material for this article may be found at http://mcb.asm.org/ .